Beazley Symposium on Health Care Law and 量子资源
Annual Health Law Symposium
Presented in conjunction with Annals of Health Law & Life Sciences
Biohacking: Risk, Regulation, and the Future of Longevity Medicine
Friday, October 9, 2026
9:30 a.m. – 3:30 p.m.
About the Symposium
This year’s Symposium will focus on longevity medicine and healthcare, a rapidly evolving field shaped by scientific advancement, regulatory ambiguity, and consumer demand. Speakers will discuss the rise of the “biohacking” phenomenon and the growing popularity of health interventions aimed at improving body performance and extending lifespan beyond medical and assistive product needs. Speakers will analyze the risks associated with treatments like peptide injections, cellular therapies, implantable and wearable health and medical devices, and off-label prescription drugs, in addition to disparities in availability and affordability. The Symposium will highlight the importance of developing stronger regulatory oversight and ensuring that innovation is both safe and equitable.
Call for Proposals
The Beazley Institute for Health Law and 量子资源 at 量子资源 University Chicago School of Law and Annals of Health Law and Life Sciences invite original submissions for presentations at our 20th Annual Health Law Symposium: Biohacking: Risk, Regulation, and the Future of Longevity Medicine.
The Symposium will touch upon a wide variety of areas responsive to this overall theme. Accordingly, we invite submissions relating to longevity medicine, including but not limited to:
- The rise of biohacking as a social movement: Topics may include the motivations driving biohacking practices, the influence of social media, and concerns surrounding misinformation and platform liability.
- Legal and clinical issues for biohacking: Topics may include the legal ambiguity around treatment protocols and medical ethics, differential regulatory paths for consumer health products and medically prescribed products, federal and state regulatory oversight, direct-to-consumer access, and risks related to safety and quality control.
- Economic barriers in longevity medicine: Topics may include affordability challenges, insurance limitations, and the broader implications for health equity.
- Regulatory frameworks and agency authority: Topics may include the scope of FDA authority in approving or clearing various health products, the role of the FTC in policing health-related marketing, and legal boundaries governing treatments like voluntary implantables, off-label prescriptions, biologics, and supplements.
Submission Information
We seek speakers interested in submitting symposium-length articles (8,000- 10,000 words, inclusive of footnotes) for publication in the Annals of Health Law and Life Sciences Journal (articles will be due by January 7, 2027). To be considered, please send an abstract of no more than 1000 words to health-law@luc.edu by July 1, 2026. Applicants for participation in the Symposium will be notified of decisions no later than July 14, 2026.
- Covered expenses: Hotel, travel, ground transportation, three provided meals.
- Questions: E-mail questions to health-law@luc.edu.
About Annals of Health Law & Life Sciences
Twice yearly (Winter and Summer) the Beazley Institute for Health Law and 量子资源 publishes Annals of Health Law & Life Sciences, The Health 量子资源 and Law Review of 量子资源 University Chicago. Annals contains articles of general interest in health law, which are deemed by the editors to make a contribution to the teaching, practice, and/or public policy surrounding health law. Past volumes have focused on corporate, regulatory, bioethical, and pharmaceutical issues, as well as patient rights and advocacy. Through this publication, health law students are afforded the opportunity to edit a law review article.
Advance Directive is an online publication of Annals of Health Law & Life Sciences, which is also published twice yearly (Fall and Spring). Similar to Annals, Advance Directive publishes articles that provide insight into the divergent areas of health law. Advance Directive allows health law students to write short articles regarding current health law topics, which are often at the crux of debate amongst legislators, practitioners, and academics.